20. Humphries JD, Wang P, Streuli C, Geiger B, Humphries MJ, et al. (2007) Vinculin controls focal adhesion formation by direct interactions with talin and actin. J Cell Biol 179: 1043–1057. 21. Mierke CT, Kollmannsberger P, Zitterbart DP, Diez G, Koch TM, et al. (2010) Vinculin facilitates cell invasion into three-dimensional collagen matrices. J Biol Chem 285: 13121–13130. 22. Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, et al. (2008) Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol 10: 1027–1038. 23. Seo S, Nakamoto T, Takeshita M, Lu J, Sato T, et al. (2011) Crk-associated substrate lymphocyte type regulates myeloid cell motility and suppresses the progression of leukemia induced by p210Bcr/Abl. Cancer Sci 102: 2109–2117. 24. Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandropoulos K, et al. (2006) HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene 25: 1721–1732. 25. Lucas JT, Jr., Salimath BP, Slomiany MG, Rosenzweig SA (2010) Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent. Oncogene 29: 4449–4459. 26. Izumchenko E, Singh MK, Plotnikova OV, Tikhmyanova N, Little JL, et al. (2009) NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res 69: 7198–7206. 27. Bui LC, Tomkiewicz C, Chevallier A, Pierre S, Bats AS, et al. (2009) NEDD9/ Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity. Oncogene 28: 3642–3651. 28. Kim SH, Xia D, Kim SW, Holla V, Menter DG, et al. (2010) Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells. Cancer Res 70: 4054–4063. 29. Kong C, Wang C, Wang L, Ma M, Niu C, et al. (2011) NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer. PloS ONE 6: e22666. 30. Fraley SI, Feng Y, Krishnamurthy R, Kim DH, Celedon A, et al. (2010) A distinctive role for focal adhesion proteins in three-dimensional cell motility. Nat Cell Biol 12: 598–604. 31. Pugacheva EN, Golemis EA (2005) The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome. Nat Cell Biol 7: 937–946. 32. Dadke D, Jarnik M, Pugacheva EN, Singh MK, Golemis EA (2006) Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle. Mol Biol Cell 17: 1204–1217. NEDD9 Stabilization of Focal Adhesions 33. Nakamoto T, Sakai R, Honda H, Ogawa S, Ueno H, et al. (1997) Requirements for localization of p130cas to focal adhesions. Mol Cell Biol 17: 3884–3897. 34. Ruest PJ, Shin NY, Polte TR, Zhang X, Hanks SK (2001) Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and Src. Mol Cell Biol 21: 7641–7652. 35. Fincham VJ, Frame MC (1998) The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility. EMBO J 17: 81–92. 36. Bradshaw LN, Zhong J, Bradbury P, Mahmassani M, Smith JL, et al. (2011) Estradiol stabilizes the 105-kDa phospho-form of the adhesion docking protein NEDD9 and suppresses NEDD9-dependent cell spreading in breast cancer cells. Biochimica et Biophysica Acta - Molecular Cell Research 1813: 340–345. 37. Bradbury P, Mahmassani M, Zhong J, Turner K, Paul A, et al. (2012) PP2A phosphatase suppresses function of the mesenchymal invasion regulator NEDD9. Biochim Biophys Acta. Molecular Cell Research 1823: 290–297. 38. Huttenlocher A, Ginsberg MH, Horwitz AF (1996) Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J Cell Biol 134: 1551–1562. 39. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, et al. (2003) Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160: 267–277. 40. Mierke CT, Kollmannsberger P, Zitterbart DP, Smith J, Fabry B, et al. (2008) Mechano-coupling and regulation of contractility by the vinculin tail domain. Biophys J 94: 661–670. 41. Seo S, Asai T, Saito T, Suzuki T, Morishita Y, et al. (2005) Crk-associated substrate lymphocyte type is required for lymphocyte trafficking and marginal zone B cell maintenance. J Immunol 175: 3492–3501. 42. Lees JG, Bach CTT, Bradbury P, Paul A, Gunning PW, et al. (2011) The actin- associating protein Tm5NM1 blocks mesenchymal motility without transition to amoeboid motility. Oncogene 30: 1241–1251. 43. Cowell LN, Graham JD, Bouton AH, Clarke CL, O’Neill GM (2006) Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway. Oncogene 25: 7597–7607. 44. Bach CT, Schevzov G, Bryce NS, Gunning PW, O’Neill GM (2010) Tropomyosin isoform modulation of focal adhesion structure and cell migration. Cell Adh Migr 4: 226–234. 45. Zamir E, Katz BZ, Aota S, Yamada KM, Geiger B, et al. (1999) Molecular diversity of cell-matrix adhesions. J Cell Sci 112(Pt 11): 1655–1669. PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e35058